Wall Street Unplugged - What's Really Moving These Markets

Welcome back to another episode of Wall Street Unplugged! After a crazy week and the successful launch of my brand-new newsletter, Curzio Research Advisory… it’s time to get back to business. On this week’s show I’m jumping right back into my favorite sector, junior mining. Today I welcome back a guest that has made listeners a lot of money over the years… He is the co-founder & CEO of Gold Standard Ventures (NYSE: GSV), Jonathan Awde. The first time Jonathan was on the show, his exploration company, Gold Standard Ventures, was under 40 cents. Today, the company is over $2.00 per share. To start off the interview, Jonathan catches listeners up to date… breaking down their recent game-changing acquisitions. Including a 21,000 acre acquisition which increases their holdings at the south end of Nevada’s Carlin Trend by 66%.  Gold Standard Ventures now holds the second largest contiguous land package on Nevada’s Carlin Trend. It’s known as one of the most “prolific” gold producing areas in the world. But this isn’t the best part. For such a small exploration company, Gold Standard Ventures has been building an extremely strong treasury. As Jonathan will explain in the interview, several significant investors have bought stake in the company since we’ve last talked. One corporate investor in particular is Goldcorp. They are the 3rd largest gold producer in the world. And they recently increased their stake in the company over 10%. This is a huge factor going forward. To add to the story… Jonathan gives listeners his 2017 outlook. As GSV plans to take on their biggest, most ambitious drilling program in the history of the company, Jonathan claims this is going to be their “biggest year” to date. So investors: If you felt you missed the boat last occasion… It’s time to take another look. At current levels, the stock looks attractive. Plus, the share price is coming off a 27% pullback from it’s highs. The company seems to be on the cusp of a rebound considering all the catalysts Jonathan unfolds in front of us today. PS – Don’t leave after my guest signs off. Educational Segments are back! On this episode I’m taking the Walt Disney company under the microscope. After Goldman Sach’s recent “buy” recommendation, I’m stepping in to pull apart the truth from all the noise.

Welcome back to another episode of Frankly Speaking! After news of recent Syria attacks, defense stocks have seen a bit of a spark. We've seen Raytheon (RTN) surge 3%, Lockheed Martin (LMT) rise 1.2%, and Northrop Grumman (NOC) add .9%. Is it time to place our bets? ...Or is it too late? Tune in as I take the defense sector under the microscope. Also, as many of you have heard, my newsletter Curzio Research Advisory is finally live. If you are having any trouble getting the offer, or have had any technical issues... this is the podcast to listen to. Special thanks to Joe, Sid, and Allen. Keep the questions coming! Good Investing, Frank Curzio

Welcome back to another episode of Wall Street Unplugged! This week’s show is a special one… It’s the moment we’ve all been waiting for. My brand-new flagship newsletter, Curzio Research Advisory, is finally live. That’s right, it’s official. And before my guest signs on, I’ve prepared a special segment to tell you all about it. These are specific instructions, tips, and details on how listeners can make the best out of this limited-time opportunity. I’m then joined by Managing Director & Portfolio Manager at Point View Wealth Management - John Petrides. Today, John and I break down a number of topics - politics, emerging markets, economics, you name it… John knows it all. But to start off the interview, John brings up something that’s rarely addressed… It’s a period of time he calls the “Beartrap.” And we’re in the middle of it. It’s the time in between earnings seasons and, as John explains, when investors must be alert. This is when there’s a ton of headline risks... and when individual investors overly focus on short-term economic data. As John puts it, "we don’t want to make long-term decisions based on short-term risks.” Switching gears, John shares with listeners his favorite play in the energy sector. Just last week, this company announced a “home-run” deal. And as it continues to free up cash, lower debt, and buy back shares… this under-the-radar stock is poised for something huge. As always, before John signs off, he highlights his favorite sector going forward… The ultimate hedge against Trump.

Welcome back to another episode of Frankly Speaking! First and foremost… I want to thank everybody for their patience. My flagship newsletter, Curzio Research Advisory is just a few days away from launch. And today, without saying too much, I wanted to cover some last minute details. This will include some hints on what to expect, prices, my lifetime offer, and the special reports attached. And please, if you have any questions or concerns about receiving the offer… Email me directly at Frank@CurzioResearch.com. I want to make sure all of my followers have immediate access.  My next question comes from Chadwick. He brings up a mining stock located in a region I rarely cover - South Africa. As far as mining stocks go, is South Africa’s jurisdiction worth exploring? I then break down one of the most important factors to look for before any investment. This is something I check before I dive into any numbers or technicals. It's insider trading. Insider information is extremely valuable to us (individual investors). Insider trading shows insider confidence. Let's face it, the mangers and front office executive will always know something that we don't. Insider's buy for only one reason... And timing your investments with theirs can result in huge gains. Tune in to discover how to find them online. After all, it's free. Special thanks to George, Chadwick, Robert, Peter, and Brian. Keep the questions coming! Other topics talked about: The buying hated stocks methodology, and my thought process behind fertilizer/ farming investing.

Welcome back to another episode of Wall Street Unplugged! This week I’m joined by longtime friend, Andrew Horowitz. Andrew is the host of the financial podcast – The Disciplined Investor. He is also the CEO and Founder of Horowitz & Company. To start off the interview, Andrew and I talk about the #1 catalyst in the markets right now… We’re talking politics. As Andrew says, “everything the governments talk about, the markets hang their hats on.” And he couldn’t be more spot on. The stock market just had it’s worst week since the election after Donald Trump failed to rally support for his healthcare plan. And with markets already trading at a premium, investor sentiment is beginning to pull back. As we all know, the markets have reached new heights solely on anticipation of Trump’s pro-growth policies. But will they actually be carried out? Tune in as Andrew explains today’s overarching issue… And why paying close attention to the guys upstairs (the government) is now more important than ever before. Then, if there’s one thing that Andrew nails every time he’s on the podcast… It’s his short picks. To end the interview Andrew presents listeners with two more. This is a thesis investors don’t want to miss.

Welcome back to another episode of Frankly Speaking! Keep the questions coming at Frank@CurzioResearch.com Good Investing, Frank Curzio

Welcome back to another episode of Wall Street Unplugged!  On today’s show I bring back the rockstar of CEO’s – Keith Neumeyer. Keith is a pioneer in the resource industry. He has successfully built three publicly traded mining companies And today, he catches us up to date on two of them - First Mining Finance (FF.V), and First Majestic Silver (AG). I first invited Keith on the show directly after the launch of his first gold venture, First Mining Finance. At the time, the stock was at just at $.30. Today, the stock price rests right around $1. Keith has a knack for buying assets at the right time. In other words, he’s an expert at timing the market. As you’ll hear on the show, “what you pay for assets is how you create value” is his motto. When he launched First Mining Finance, gold prices were sitting at record-level lows. And when commodity prices finally rebounded last year, his company took off – reaching gains well over 300%. Today Keith gives us his outlook for the company going forward, along with the yellow-metal itself. Moving on, we turn our focus to Keith’s other company, First Majestic Silver (AG). First Majestic is the largest Silver producer in the world. And looking at the numbers, The company has everything in place.  Then for today’s Educational Segment, we take a closer look at one of my favorite market strategies – Buying hated stocks.  One-by-one, I break down a list of Wall Street’s most hated companys. These are the stocks that everyone avoids; and stocks that have “sell” ratings across the board. This includes names like Twitter, Valeant, Sears, Macy’s, Gamestop, and Target. By any means, what I am about to introduce to you is not an easy strategy… But when you follow these steps, it can work like a charm.  This is the stuff that has led me to my greatest gains in my career. And it’s the only contrarian formula you need to know.

Welcome back to another episode of Frankly Speaking!   Think you got what it takes to work with Jim Cramer?   My first question of the day comes from Jim himself. He’s looking for some help. And I promised him I would reach out to you - my listeners.   If you didn’t know, I worked under Jim for 5 years at TheStreet.com as an Senior Analys... And I have never had a better learning experience outside of that 5 year span.   It was a job of a lifetime. And I wouldn’t be here today without it. If interested in the opportunity, be sure to tune in for the specific instructions. I’ll see what I can do.   Moving on, and after some March Madness talk (sorry, I just had to mention my Jayhawks), we get back on track [14:40]. This is when I take a closer look at the gold stock, Timmins Gold Corp (TGD).   Tune in as I take listeners, start to finish, throughout my entire analysis process. These are my 6 never-skip qualifications before I make any mining investment.   This is the stuff that has saved me a fortune.   Special thanks to Zach, Darren, & Reymond.   Keep them coming! Just email your questions to me at Frank@CurzioResearch.com, with the subject line: Frankly Speaking

Welcome back to another episode of Wall Street Unplugged! On today’s show, I introduce listeners to Panna Sharma. Panna is the CEO and President of a small-cap, clinical and diagnostics company - Cancer Genetics (CGIX). Panna brings together everything you need to know about the company. It’s core focus? Precision medicine. And the drug industry is betting big on it… To start off the interview, Panna and I talk about how treatments and innovations in the industry are rapidly changing… In the past, companies were betting on single drugs and routine treatments to cure all. But considering the complex, biological diversity of something like cancer, there has never been and never will be “one answer.” Panna explains how the industry and his company in particular are making huge strides in the right direction. Recently, we’ve seen a transfer from trial-and-error medicines to evidence-based medicine. And instead of dividing patients into groups based on thousands of outcomes, today you can now treat patients baseds on the details of their own unique genes. The trend is the death of “one size fits all.” And companies like Cancer Genetics are sitting at the center of it. The business model, as Panna says, comes from a “multi-tiered” approach. The company focuses on drug design, clinical trials, and diagnosis development. It’s a strategy leveraged from genomic data, innovation, and collaboration. And it benefits both side’s of the equation - the world of biotech/pharma development, as well as the patients. Now for those that are familiar with my podcast, you know that I’m picky... And you probably have heard about my show’s golden rule -- To never bring on a CEO of a company I don’t personally believe in. In other words, don’t take this as a sales pitch. This company, no doubt, has long-term growth potential. And Panna has all the right answers to back it up… After looking at what’s actually on paper, it was difficult to turn away. For one, there’s high insider ownership. But more important, Cancer Genetics is working with 8 out of the top 10 biotech companies. A small company with strong partnerships with some of the biggest names in the industry is huge. This commercial traction alone is their strongest catalyst going forward. The current share price is sitting just above $2.00. And valuations are at a steep discount compared to other traditional genomic diagnosis companies. But before taking any action, note that earnings are only one week away. And considering the current shape of the industry, be sure to do some homework. Again, this is a long-term play… And resources like this interview are a great place to start. Not only is this a company that should be on everyone’s radar, this is one of those “feel good” stories. And I’m more than happy to introduce listeners to the opportunity. Just click here to listen…

Welcome back to another episode of Frankly Speaking! My new newsletter, Curzio Research Advisory is just a couple weeks away... And to start off today's episode, I need to clear up some confusion. Listeners will hear all about my special offer, how to sign up, and a general description of what the newsletters entails. And as you'll hear, there's more to it than just stock picks... Moving on, today's main segment covers one of the most hated stocks on Wall Street - Target (TGT). All the analyst are negative... the price is sitting at multi-year lows... and the retail sector is spiraling downwards. I always advise my listeners to "never catch a falling knife" but for Target, this isn't the case anymore. Tune in as I explain why the risk/reward looks favorable. There are 3 major catalysts that I believe will finally drive this depressed stock higher. Thanks for listening and good investing! Frank Curzio